Brandtree

Who owns Foracort?

Foracort is owned by Cipla (India, NSE: CIPLA).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Evidence: Cipla Limited Integrated Annual Report 2025-26. Last checked .

Key facts

Current owner
Cipla Limited reported
Owner HQ
🇮🇳 India, Mumbai
Origin
🇮🇳 India
Category
Healthcare & pharma › Drug makers › Pharmaceuticals
Parent ticker
NSE: CIPLA BSE: 500087
Last verified
· 1 sources

About Foracort

Foracort is the flagship brand of Cipla's respiratory business in India, which holds about 26% of the Indian respiratory market. Its range includes the triple-therapy Foracort G, launched with the Ciphaler inhaler. The 2025-26 annual report says it became the first brand in the Indian pharmaceutical market to pass ₹1,000 crore in sales and held the market's top position all year.

Ownership timeline of Foracort

  1. Current owner Cipla [1] reported

Where Foracort sits in Cipla

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Foracort sits in Cipla Tree of 7 brands under Cipla. Cipla Foracort Astaberry Cipladine Cofsils Nicotex Omnigel and 1 more

Open the full Cipla ownership tree →

See the full Cipla brand portfolio (7) →

Other brands owned by Cipla

Cipla controls 7 brands on Brandtree.

All Cipla brands →

Other brands in pharmaceuticals, and who owns them

The 27 brands in pharmaceuticals on Brandtree belong to 10 owners. The largest is Teva, with 4.

BrandOwnerOwner based in
Amphadase Amphastar 🇺🇸 United States
ILUVIEN ANI Pharmaceuticals 🇺🇸 United States
Momate Glenmark 🇮🇳 India
Ajovy Teva 🇮🇱 Israel
Celebrex Viatris 🇺🇸 United States
Brekiya Amneal 🇺🇸 United States
Evra Richter 🇭🇺 Hungary
Habitrol Dr. Reddy's 🇮🇳 India

Every brand in pharmaceuticals and its owner →

About the owner: Cipla

Cipla is a publicly listed company headquartered in Mumbai, India, founded in 1935. Brandtree records 7 brands under its control, and it is listed as NSE: CIPLA and BSE: 500087.

Cipla is a Mumbai drugmaker founded by Dr K A Hamied in August 1935. Its 2025-26 annual report calls it India's third-largest pharmaceutical company and second in the South African prescription market, with 48 manufacturing sites and over 31,000 permanent employees. Consolidated revenue was ₹28,163 crore in the year to 31 March 2026. Its Indian consumer health business is run by a wholly owned subsidiary, Cipla Health Limited.

Cipla: full profile, brands and acquisition history →

🇮🇳 Foracort and other Indian brands

Brandtree records a controlling owner for 279 brands that began in India. 9 of them (3%) are now controlled by a company headquartered in another country; Foracort is not one of them.

All Indian brands and who owns them →

Frequently asked questions

Who is the parent company of Foracort?

The parent company of Foracort is Cipla, a publicly listed company headquartered in India.

Is Foracort Indian?

Yes. Foracort originated in India and its owner, Cipla, is also headquartered in India.

Is Foracort still owned by Cipla?

Yes. As of 21 October 2026, Foracort is still owned by Cipla. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Cipla Limited Integrated Annual Report 2025-26 — Cipla Limited, Annual report; retrieved 21 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.